NR3C2 Gene Hypertension Early Onset Genetic Test sale cost 4400 AED
GP1BA Gene Bernard Soulier Syndrome Type A2 Genetic Test sale cost 4400 AED GP1BA Gene Bernard Soulier Syndrome Type A2 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
STIM1 Gene Stormorken Syndrome Genetic Test sale cost 4400 AED STIM1 Gene Stormorken Syndrome Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

NR3C2 Gene Hypertension Early Onset Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NR3C2 Gene Hypertension Early Onset Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the NR3C2 gene, which have been associated with early-onset hypertension. Hypertension, or high blood pressure, is a common condition that can lead to serious health issues such as heart disease, stroke, and kidney failure. Early detection through genetic testing can be crucial in managing and potentially mitigating the risks associated with this condition.

The NR3C2 gene plays a significant role in the body’s regulation of sodium reabsorption in the kidneys, which in turn affects blood pressure. Mutations in this gene can disrupt normal function, leading to an increased risk of developing hypertension at an early age. By identifying individuals with these genetic mutations, healthcare providers can implement early intervention strategies, including lifestyle modifications and targeted therapies, to reduce the risk of hypertension-related complications.

The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of mutations in the NR3C2 gene. Results from this test can provide valuable insights into an individual’s risk of developing early-onset hypertension, enabling personalized medical care and preventive measures.

Given the potential health implications of early-onset hypertension, the NR3C2 Gene Hypertension Early Onset Genetic Test is a valuable tool for individuals with a family history of hypertension or those who have early signs of high blood pressure. It represents a proactive approach to health management, emphasizing the importance of genetic factors in understanding and treating hypertension.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NR3C2 Gene Hypertension Early Onset Genetic Test

Welcome to DNA Labs UAE, where we offer the NR3C2 gene hypertension early onset genetic test. This test aims to identify any mutations or variations in the NR3C2 gene that may contribute to the development of early-onset hypertension.

Test Components and Price

  • Components: Blood or Extracted DNA or One drop Blood on FTA Card
  • Price: 4400.0 AED

Sample Condition

The sample required for this test can be either blood, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

After the sample is collected, the report will be delivered within 3 to 4 weeks.

Method

This test utilizes NGS (Next-Generation Sequencing) technology to analyze the DNA sequence of genes, including the NR3C2 gene.

Test Type

The NR3C2 gene hypertension early onset genetic test falls under the category of vascular diseases.

Doctor

This test can be ordered by a general physician.

Test Department

The NR3C2 gene hypertension early onset genetic test is conducted in our Genetics department.

Pre Test Information

Before undergoing the NR3C2 gene hypertension early onset NGS genetic DNA test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the NR3C2 gene hypertension early onset NGS genetic DNA test gene NR3C2.

Test Details

The NR3C2 gene is responsible for encoding the mineralocorticoid receptor, which plays a crucial role in regulating blood pressure and fluid balance in the body. Mutations in the NR3C2 gene have been associated with early-onset hypertension, a condition characterized by high blood pressure that develops at a young age.

NGS genetic testing is a technique used to analyze the DNA sequence of genes, including the NR3C2 gene, in order to identify any mutations or variations that may be present. This type of genetic testing can provide valuable information about an individual’s genetic predisposition to early-onset hypertension and help guide treatment and management strategies.

By analyzing the NR3C2 gene through NGS genetic testing, healthcare professionals can identify specific mutations or variations that may be contributing to the development of early-onset hypertension. This information can be used to develop personalized treatment plans and interventions to effectively manage the condition.

It’s important to note that genetic testing alone may not be sufficient to diagnose or predict early-onset hypertension. It is typically used in conjunction with other clinical evaluations and assessments to provide a comprehensive understanding of an individual’s health and genetic profile. Additionally, genetic testing can also provide insights into an individual’s risk for other genetic conditions and diseases beyond hypertension.

Test Name NR3C2 Gene Hypertension early onset Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Vascular Diseases
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NR3C2 Gene Hypertension early onset NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NR3C2 Gene Hypertension early onset NGS Genetic DNA Test gene NR3C2
Test Details

The NR3C2 gene is responsible for encoding the mineralocorticoid receptor, which plays a crucial role in regulating blood pressure and fluid balance in the body. Mutations in the NR3C2 gene have been associated with early-onset hypertension, a condition characterized by high blood pressure that develops at a young age.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze the DNA sequence of genes, including the NR3C2 gene, to identify any mutations or variations that may be present. This type of genetic testing can provide valuable information about an individual’s genetic predisposition to early-onset hypertension and help guide treatment and management strategies.

By analyzing the NR3C2 gene through NGS genetic testing, healthcare professionals can identify specific mutations or variations that may be contributing to the development of early-onset hypertension. This information can be used to develop personalized treatment plans and interventions to manage the condition effectively.

It’s important to note that genetic testing alone may not be sufficient to diagnose or predict early-onset hypertension. It is typically used in conjunction with other clinical evaluations and assessments to provide a comprehensive understanding of an individual’s health and genetic profile. Additionally, genetic testing can also provide insights into an individual’s risk for other genetic conditions and diseases beyond hypertension.

SKU: TEST-3531 Category:

Related products